Page last updated: 2024-10-22

amitriptyline and Acute Relapsing Multiple Sclerosis

amitriptyline has been researched along with Acute Relapsing Multiple Sclerosis in 1 studies

Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.

Research Excerpts

ExcerptRelevanceReference
"We describe an MS patient who developed migraine headaches, which followed a specific pattern coincident with interferon-beta administration."1.33Migraines linked to interferon-beta treatment of multiple sclerosis. ( Fast, A; Khromov, A; Nissinoff, J; Segal, M, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Khromov, A1
Segal, M1
Nissinoff, J1
Fast, A1

Other Studies

1 other study available for amitriptyline and Acute Relapsing Multiple Sclerosis

ArticleYear
Migraines linked to interferon-beta treatment of multiple sclerosis.
    American journal of physical medicine & rehabilitation, 2005, Volume: 84, Issue:8

    Topics: Adult; Amitriptyline; Analgesics, Non-Narcotic; Female; Humans; Interferon-beta; Migraine Disorders;

2005